Leading charity reveals major gaps in UK childhood cancer research funding
A new charity report has revealed major gaps in childhood cancer research funding despite strong investment in treatment development.
Mapping childhood cancer research: CCLG launches vital new report on UK research funding
CCLG: The Children & Young People’s Cancer Association has published a new report revealing major gaps in childhood cancer research funding, despite strong investment in treatment development.
Mansfield family’s fundraising in memory of “kind and brave” 11-year-old fuels childhood leukaemia research
A Mansfield family’s fundraising in memory of their 11-year-old son and brother has helped fund two new research projects into childhood acute myeloid leukaemia (AML).
Kent auntie’s fundraising in nephew’s memory supports new childhood leukaemia research
A Staplehurst lady’s fundraising in memory of her “cheeky, mischievous” three-year-old nephew has helped support vital new childhood cancer research.
Surprising science - how diabetes drugs could treat childhood leukaemia
New cancer treatments take a long time and a lot of money to develop. So, what if we could use existing drugs from other conditions to kill cancer cells?
New research aims to transform treatment for babies and children with aggressive blood cancers
CCLG: The Children & Young People’s Cancer Association is proud to announce a £600,000 collaboration with Blood Cancer UK that is funding vital new childhood leukaemia research.
CCLG Research Talks: Why use artificial intelligence with childhood cancer scans?
We talk to Dr Heather Rose about how artificial intelligence could help doctors diagnose brain tumours more quickly and accurately.
Childhood cancer charities unite to fund £700,000 of paediatric cancer research
Children with Cancer UK and CCLG: The Children & Young People’s Cancer Association have funded three major projects to improve treatments and outcomes for young cancer patients.
Innovative Little Princess Trust brain tumour research published
New research funded by the Little Princess Trust and administered by CCLG shows promise as a safer way to treat aggressive brain tumours in children.